✉news ScienceScience first seen 10 h ago, last 2 h ago, peak #6
Anthony Letai on Progress in RAS-Targeted Cancer Research
Original: Anthony Letai: The Science and Collaboration Behind Progress in RAS-Targeted Cancer Research
Cancer researcher Anthony Letai is being featured for his work on RAS-targeted cancer therapies, with attention on both the science and the collaboration driving progress in the field. RAS genes are among the most common drivers of human cancers, and drugs targeting them have been a long-sought goal in oncology.
Why now: Oncology media are highlighting Letai's commentary as RAS-targeted therapies remain a fast-moving area of cancer drug development.
Rank over time, top of the chart is #1. 7 snapshots from 10 h ago to 2 h ago.
Evidence
- Anthony Letai: The Science and Collaboration Behind Progress in RAS-Targeted Cancer Research · Oncodaily
API: https://socialmediatrends-api.osmike.com/v1/trends/1778295